Alzheimer's disease & dementia

Patient portal use explored for older adults with dementia diagnosis

Older adults with dementia diagnosis are as likely to be registered for a patient portal as those without dementia, and they have a lower portal activity metric, according to a research letter published online June 26 in ...

Medications

FDA approves Litfulo for teens, adults with alopecia areata

The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.

page 12 from 40